MedTrace Logo

Inulin in Burn-induced Insulin Resistance

NCT05532488 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-04-26

No results posted yet for this study

Summary

In this clinical trial, investigators will test the effects of dietary supplement inulin, on the reduction of insulin resistance developed as a result of burn injuryy.

Conditions

Interventions

DIETARY_SUPPLEMENT

Inulin 20 mg

Inulin can increase gut Bifidobacterium count. Bifidobacterium has beneficial effects on the metabolic profile and insulin resistance biomarkers.

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • University of Belgrade

    lead OTHER

Principal Investigators

  • Marko A Stojanović, MD, PhD · Faculty of Medicine, University of Belgrade

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Serbia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05532488 on ClinicalTrials.gov